Cadence upgraded at Ladenburg

As noted earlier, Ladenburg upgraded Cadence (CADX) to Buy from Neutral with a $5.75 price target. The firm believes that the settlement between Cadence and Perrigo (PRGO) involving Perrigo's generic version of Ofirmev is positive for Cadence.